tiprankstipranks
Trending News
More News >
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market

Bolt Biotherapeutics (BOLT) Income Statement

Compare
241 Followers

Bolt Biotherapeutics Income Statement

Last quarter (Q3 2025), Bolt Biotherapeutics's total revenue was $2.17M, an increase of 90.10% from the same quarter last year. In Q3, Bolt Biotherapeutics's net income was $-7.14M. See Bolt Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.69M$ 7.88M$ 5.73M$ 1.26M$ 231.00K
Gross Profit
$ 7.69M$ -53.67M$ -67.39M$ -74.39M$ -40.13M
Operating Expenses
$ 80.74M$ 22.53M$ 22.93M$ 18.39M$ 9.06M
Depreciation and Amortization
$ 1.78M$ 1.85M$ 1.67M$ 1.19M$ 611.00K
EBITDA
$ -66.45M$ -74.34M$ -88.66M$ -91.59M$ -48.57M
Operating Income
$ -73.05M$ -76.20M$ -90.32M$ -92.79M$ -49.18M
Other Income/Expenses
$ 9.93M$ 7.00M$ 2.22M$ -5.80M$ -11.55M
Pretax Income
$ -63.12M$ -69.20M$ -88.10M$ -98.59M$ -60.73M
Net Income
$ -63.12M$ -69.20M$ -88.10M$ -98.59M$ -60.73M
Per Share Metrics
Basic EPS
$ -1.65$ -1.83$ -2.30$ -2.79$ -1.99
Diluted EPS
$ -1.65$ -1.83$ -2.30$ -2.79$ -1.99
Weighted Average Shares Outstanding
38.18M 37.81M 37.36M 37.40M 36.25M
Weighted Average Shares Outstanding (Diluted)
38.18M 37.81M 37.36M 37.40M 36.25M
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History